YZY Bio Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Public

  • Employees
  • 68

Employees

  • Stock Symbol
  • 02496

Stock Symbol

  • Share Price
  • $0.54
  • (As of Monday Closing)

YZY Bio General Information

Description

Wuhan YZY Biopharma Co Ltd is a biotechnology company dedicated to developing bispecific antibody (BsAb)- based therapies. The Company has been forward-looking in deploying its presence in several therapeutic fields, including but not limited to tumor-associated complications, tumors, ophthalmology, and autoimmune diseases. The Company also proactively established several self-developed technology platforms, such as Y-BODY, Check-Body, and Nano-Ybody, promoting the development of more candidates to clinical stages with high efficiency.

Contact Information

Website
www.yzybio.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • No. 666, Gaoxin Avenue
  • East Lake New Technology Development Zone
  • Wuhan, Hubei
  • China
+86 027
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Drug Discovery
Stock Exchange
HKG
Vertical(s)
Corporate Office
  • No. 666, Gaoxin Avenue
  • East Lake New Technology Development Zone
  • Wuhan, Hubei
  • China
+86 027

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

YZY Bio Stock Performance

As of 16-Nov-2026, YZY Bio’s stock price is $0.54. Its current market cap is $107M with 194M shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.54 $0.51 $0.28 - $1.08 $107M 194M 100.00 -$0.02

YZY Bio Financials Summary

As of 30-Jun-2026, YZY Bio has a trailing 12-month revenue of $8.98M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 101,204 198,453 200,972 212,609
Revenue 8,977 9,297 15,025 0
EBITDA (3,823) (10,582) (12,475) (25,873)
Net Income (4,596) (11,783) (13,602) (27,096)
Total Assets 26,057 25,013 36,690 42,551
Total Debt 20,406 18,260 17,446 12,713
Public Fundamental Data provided by Morningstar, Inc. disclaimer

YZY Bio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore YZY Bio‘s full profile, request access.

Request a free trial

YZY Bio Patents

YZY Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026189439-A1 Pharmaceutical composition comprising anti-epcam and cd3 bispecific antibody Pending 13-Mar-2025
WO-2026011751-A1 Antibody formulation Pending 08-Jul-2024
WO-2025190337-A1 Method for ameliorating or treating malignant ascites using anti-epcam × cd3 bispecific antibody Pending 13-Mar-2024
WO-2024082269-A1 Application of bispecific antibody in immune cell therapy Inactive 21-Oct-2022
JP-7868145-B2 Bispecific antibodies and their applications Active 19-Nov-2021 C07K16/30
To view YZY Bio’s complete patent history, request access »

YZY Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

YZY Bio Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore YZY Bio‘s full profile, request access.

Request a free trial

YZY Bio ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view YZY Bio’s complete esg history, request access »

YZY Bio FAQs

  • When was YZY Bio founded?

    YZY Bio was founded in 2010.

  • Where is YZY Bio headquartered?

    YZY Bio is headquartered in Wuhan, China.

  • What is the size of YZY Bio?

    YZY Bio has 68 total employees.

  • What industry is YZY Bio in?

    YZY Bio’s primary industry is Pharmaceuticals.

  • Is YZY Bio a private or public company?

    YZY Bio is a Public company.

  • What is YZY Bio’s stock symbol?

    The ticker symbol for YZY Bio is 02496.

  • What is the current stock price of YZY Bio?

    As of 16-Nov-2026 the stock price of YZY Bio is $0.54.

  • What is the current market cap of YZY Bio?

    The current market capitalization of YZY Bio is $107M.

  • What is YZY Bio’s current revenue?

    The trailing twelve month revenue for YZY Bio is $8.98M.

  • What is YZY Bio’s annual earnings per share (EPS)?

    YZY Bio’s EPS for 12 months was -$0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process